急性和慢性椎源性腰骶痛综合征患者p物质浓度和神经性疼痛成分的比较特征

A. Payenok, A. Kulyk
{"title":"急性和慢性椎源性腰骶痛综合征患者p物质浓度和神经性疼痛成分的比较特征","authors":"A. Payenok, A. Kulyk","doi":"10.31612/2616-4868.3(25).2023.08","DOIUrl":null,"url":null,"abstract":"The aim. The primary aim of this study is to assess the variance in substance P concentration, taking into account pain intensity and the presence of a neuropathic component, among patients experiencing acute and chronic vertebral lumbosacral pain syndromes. \nMaterials. Measurement of substance P concentration in serum blood, evaluation of pain syndrome using the VAS scale, and assessment of pain according to the DN4 questionnaire were performed in patients receiving comprehensive treatment. A total of 125 patients were included in the study, comprising 65 patients with acute pain and 60 patients with chronic pain syndrome. \nResults. Pain ratings according to the Visual Analog Scale (VAS) among patients from the acute pain group was 7.15±1.07 on the VAS scale, while patients in the chronic pain group rated it at 6.09±0.96. On the 7th day of treatment, patients in the acute pain group reported a pain rating of 4.46±0.73, whereas those in the chronic pain group reported a rating of 4.22±0.97. The level of substance p(SP) in serum blood on the first day of treatment was 13.96±1.93 ng/mL in the acute pain group and 10.34±2.92 ng/mL in the chronic pain group. By the 7th day of treatment, the level decreased to 7.72±1.90 ng/mL in the acute pain group and 8.03±2.14 ng/mL in the chronic pain group. According to the DN4 questionnaire, neuropathic component was ascertained in 38% of patients with acute pain syndrome and 56% of participants with chronic pain. The average DN4 score in the acute pain group was 2.26±1.01, while in the chronic pain group, it was 4.53±1.02. In the group of patients with chronic pain syndrome and the presence of a neuropathic component, the level of SP was 10.89±1.78 ng/mL. In contrast, without the presence of a neuropathic component, it was 6.51±1.94 ng/mL. \nConclusions. The trajectory of acute and chronic pain syndromes in patients with lumbosacral vertebral pain syndromes exhibits dissimilarities. Patients experiencing acute pain displayed a more favorable trend characterized by a reduction in pain intensity and a decrease in pain-related neurotransmitter concentration in the bloodstream.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COMPARATIVE CHARACTERISTICS OF SUBSTANCE P CONCENTRATION AND NEUROPATHIC PAIN COMPONENT IN PATIENTS WITH ACUTE AND CHRONIC COURSES OF VERTEBROGENIC LUMBAR-SACRAL PAIN SYNDROMES\",\"authors\":\"A. Payenok, A. Kulyk\",\"doi\":\"10.31612/2616-4868.3(25).2023.08\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The aim. The primary aim of this study is to assess the variance in substance P concentration, taking into account pain intensity and the presence of a neuropathic component, among patients experiencing acute and chronic vertebral lumbosacral pain syndromes. \\nMaterials. Measurement of substance P concentration in serum blood, evaluation of pain syndrome using the VAS scale, and assessment of pain according to the DN4 questionnaire were performed in patients receiving comprehensive treatment. A total of 125 patients were included in the study, comprising 65 patients with acute pain and 60 patients with chronic pain syndrome. \\nResults. Pain ratings according to the Visual Analog Scale (VAS) among patients from the acute pain group was 7.15±1.07 on the VAS scale, while patients in the chronic pain group rated it at 6.09±0.96. On the 7th day of treatment, patients in the acute pain group reported a pain rating of 4.46±0.73, whereas those in the chronic pain group reported a rating of 4.22±0.97. The level of substance p(SP) in serum blood on the first day of treatment was 13.96±1.93 ng/mL in the acute pain group and 10.34±2.92 ng/mL in the chronic pain group. By the 7th day of treatment, the level decreased to 7.72±1.90 ng/mL in the acute pain group and 8.03±2.14 ng/mL in the chronic pain group. According to the DN4 questionnaire, neuropathic component was ascertained in 38% of patients with acute pain syndrome and 56% of participants with chronic pain. The average DN4 score in the acute pain group was 2.26±1.01, while in the chronic pain group, it was 4.53±1.02. In the group of patients with chronic pain syndrome and the presence of a neuropathic component, the level of SP was 10.89±1.78 ng/mL. In contrast, without the presence of a neuropathic component, it was 6.51±1.94 ng/mL. \\nConclusions. The trajectory of acute and chronic pain syndromes in patients with lumbosacral vertebral pain syndromes exhibits dissimilarities. Patients experiencing acute pain displayed a more favorable trend characterized by a reduction in pain intensity and a decrease in pain-related neurotransmitter concentration in the bloodstream.\",\"PeriodicalId\":34164,\"journal\":{\"name\":\"Klinichna ta profilaktichna meditsina\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinichna ta profilaktichna meditsina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31612/2616-4868.3(25).2023.08\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinichna ta profilaktichna meditsina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31612/2616-4868.3(25).2023.08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

的目标。本研究的主要目的是评估急性和慢性腰骶椎疼痛综合征患者在考虑疼痛强度和神经性成分的情况下P物质浓度的差异。材料。对接受综合治疗的患者进行血清血P物质浓度测定,采用VAS量表评价疼痛综合征,并根据DN4问卷对疼痛进行评估。研究共纳入125例患者,其中急性疼痛患者65例,慢性疼痛综合征患者60例。结果。急性疼痛组患者的VAS评分为7.15±1.07,慢性疼痛组患者的VAS评分为6.09±0.96。治疗第7天,急性疼痛组患者疼痛评分为4.46±0.73,慢性疼痛组患者疼痛评分为4.22±0.97。治疗第1天急性疼痛组和慢性疼痛组血清p物质(SP)水平分别为13.96±1.93 ng/mL和10.34±2.92 ng/mL。治疗第7天,急性疼痛组和慢性疼痛组分别降至7.72±1.90 ng/mL和8.03±2.14 ng/mL。根据DN4问卷,38%的急性疼痛综合征患者和56%的慢性疼痛患者确定了神经性成分。急性疼痛组平均DN4评分为2.26±1.01,慢性疼痛组平均DN4评分为4.53±1.02。慢性疼痛综合征伴神经性成分组SP水平为10.89±1.78 ng/mL。相比之下,没有神经病变成分的存在,它是6.51±1.94 ng/mL。结论。腰骶椎疼痛综合征患者的急性和慢性疼痛综合征表现出不同的轨迹。急性疼痛患者表现出更有利的趋势,其特征是疼痛强度降低,血流中与疼痛相关的神经递质浓度降低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
COMPARATIVE CHARACTERISTICS OF SUBSTANCE P CONCENTRATION AND NEUROPATHIC PAIN COMPONENT IN PATIENTS WITH ACUTE AND CHRONIC COURSES OF VERTEBROGENIC LUMBAR-SACRAL PAIN SYNDROMES
The aim. The primary aim of this study is to assess the variance in substance P concentration, taking into account pain intensity and the presence of a neuropathic component, among patients experiencing acute and chronic vertebral lumbosacral pain syndromes. Materials. Measurement of substance P concentration in serum blood, evaluation of pain syndrome using the VAS scale, and assessment of pain according to the DN4 questionnaire were performed in patients receiving comprehensive treatment. A total of 125 patients were included in the study, comprising 65 patients with acute pain and 60 patients with chronic pain syndrome. Results. Pain ratings according to the Visual Analog Scale (VAS) among patients from the acute pain group was 7.15±1.07 on the VAS scale, while patients in the chronic pain group rated it at 6.09±0.96. On the 7th day of treatment, patients in the acute pain group reported a pain rating of 4.46±0.73, whereas those in the chronic pain group reported a rating of 4.22±0.97. The level of substance p(SP) in serum blood on the first day of treatment was 13.96±1.93 ng/mL in the acute pain group and 10.34±2.92 ng/mL in the chronic pain group. By the 7th day of treatment, the level decreased to 7.72±1.90 ng/mL in the acute pain group and 8.03±2.14 ng/mL in the chronic pain group. According to the DN4 questionnaire, neuropathic component was ascertained in 38% of patients with acute pain syndrome and 56% of participants with chronic pain. The average DN4 score in the acute pain group was 2.26±1.01, while in the chronic pain group, it was 4.53±1.02. In the group of patients with chronic pain syndrome and the presence of a neuropathic component, the level of SP was 10.89±1.78 ng/mL. In contrast, without the presence of a neuropathic component, it was 6.51±1.94 ng/mL. Conclusions. The trajectory of acute and chronic pain syndromes in patients with lumbosacral vertebral pain syndromes exhibits dissimilarities. Patients experiencing acute pain displayed a more favorable trend characterized by a reduction in pain intensity and a decrease in pain-related neurotransmitter concentration in the bloodstream.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
34
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信